Navigation Links
FDA warnings against use of antipsychotic drugs for elderly,,

The Food and Drug Administration (FDA) of US had warned the public and medical professionals against use of //certain drugs broadly called as atypical antipsychotic drugs on elderly patients with dementia.

The drugs, aripiprazole, olanzapine, quetiapine, risperidone, clozapine and ziprasidone, are approved for the clinical treatment of schizophrenia and mania. Use of these drugs to treat elderly patients with dementia and behavior disorders have resulted in a very high incidence of deaths. Studies conducted had showed that the drugs are as much as 1.6 times riskier than that of any other drugs. These drugs which again can be divided into three classes based on their composition, are all equally have a high risk of death due to cardiac problems associated with them when used on geriatric patients.

FDA has requested that the manufacturers of these drugs do change the label of these medications to include the warning against use of them in geriatric patients with dementia. The warning must be boxed to catch the maximum attention and must say that they are not approved for treating the behavioral disorders associated with dementia. The organization had also requested the physicians prescribing these drugs for behavioral problems in elderly to review the situation.

Reference: : Food and Drug Administration, US, news release
'"/>




Page: 1

Related medicine news :

1. Fresh warnings to doctors regarding abortion pill
2. Opposition: Government turned a deaf ear to warnings about dwindling health care services
3. FDA issues warnings on Three Popular Asthma drug labels
4. Anlene brand of milk products will carry warnings about blood-clotting risks
5. The need for cancer warnings on alcohol packaging
6. Graphic warnings on cigarette packets might just do the trick!
7. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
8. Man against HIV – new vaccine ready for human trials
9. Antibiotics losing their power against acne
10. South Africa Wins landmark case against pharmaceutical giants
11. Vitamin E, the latest warrior against diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... ... May 02, 2016 , ... Over $60 Billion is spent annually on products ... toys, leading product review site for Toys, Tots, Pets & More (TTPM) announced the ... Spring Showcase at the Metropolitan Pavilion in New York City. , Chosen from a ...
(Date:5/2/2016)... NY (PRWEB) , ... May 02, 2016 , ... This ... reopened for its 2016 guest season which runs through October. Omega is offering a ... . , “There has never been such widespread interest in or need ...
(Date:5/2/2016)... County, CA (PRWEB) , ... May 02, 2016 , ... ... now linking dental health and cognitive decline. According to the research, which was published ... have some degree of cognitive decline, and about 5.4 million Americans have Alzheimer’s disease. ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... Brentwood, TN (PRWEB) , ... May 02, 2016 ... ... American Addiction Centers (AAC) event, will be held at the Bellagio Hotel in ... National Association of Social Work (NASW) will be co-hosting the event. , This ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... TOKYO , April 28, 2016 /PRNewswire/ ... Ahuja , George Phillips und ... wachsenden Unternehmens    ArisGlobal®, ein ... Life Sciences, gab heute bekannt, dass neue ... wachsenden Unternehmens gestoßen sind, die vielfältige Erfahrungen ...
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
Breaking Medicine Technology: